Cognizant announced that Thomas Gassenbauer will join the company as Managing Director for Switzerland, effective November 1, 2021.

As a member of Cognizant’s DACH leadership team, Thomas Gassenbauer will be based in Zürich and lead all aspects of Cognizant’s operations in Switzerland, including strategic planning, commercial development, and client delivery.

Thomas Gassenbauer will also be part of the wider DACH leadership team, bringing over 30 years of experience in advising clients across a broad set of technology and services sales, BPO / ITO program management and service delivery. In his most recent role, he served as IBM’s Global Client Director for Financial Services, responsible for one of IBM’s largest global clients. Prior to IBM, Thomas Gassenbauer spent 11 years in different IT engineering and services roles at Novartis and the healthcare industry.

Thomas Gassenbauer will report to Dr. Rolf Werner, Head of DACH, Cognizant.

He holds an MA in Business and Economics from the University of Basel, Switzerland and is an alumnus of London Business School and Swiss Finance Institute.

“I am thrilled to welcome Thomas to the Cognizant team as our new head of Switzerland,” said Dr. Rolf Werner, Head of DACH, Cognizant. “We have a solid foundation in the country on which to build, and Thomas’ leadership experience across both internal and client transformation roles will help us accelerate growth in Switzerland as well as the entire DACH region.”

“I am excited to join Cognizant at this time and become the Managing Director for Switzerland,” said Thomas Gassenbauer, Managing Director, Switzerland, Cognizant. “I am deeply passionate about people, services and technology and I now look forward to building and leading high-performance teams in Switzerland and the DACH region that engineer growth for our clients and take their digital transformation agenda to the next level.”

Cognizant has been present in Switzerland since 2003, servicing some of the biggest global players in the banking and finance, insurance, life sciences and pharma, retail and consumer goods and the manufacturing industries from there.